Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
TBPH

Updated 10/6/2026, 8:56 AM ET.

TBPH

Theravance Biopharma, Inc.

Sale$226,793

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

13,314 shat $17.03Filed Sep 17, 5:52 PM ET
Filing
TBPH

Theravance Biopharma, Inc.

Sale$119,397

Samaha Eli

10% owner

6,964 shat $17.14Filed Jul 8, 4:13 PM ETFiling

Read from public SEC filings. Not financial advice.